Zidovudine Capsule Clinical Trials
- Capsule Endoscopic Miss Rates Determined by Back-to-Back Capsule Endoscopy
ClinicalTrials.gov Identifier: NCT00530231 - Recruiting
Capsule Endoscopy
- Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris
ClinicalTrials.gov Identifier: NCT00145106 - Completed
Acne Vulgaris
- Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (daily dosing)
ClinicalTrials.gov Identifier: NCT00048516 - Completed
Renal Insufficiency, Chronic
- Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis
ClinicalTrials.gov Identifier: NCT00091975 - Completed
Kidney Disease
- Evaluate Efficacy and Safety of Tolterodine Extended Release Capsule Compared with Tolterodine Immediate Release Tablet in Patients with Symptoms of Overactive Bladder
ClinicalTrials.gov Identifier: NCT00139724 - Completed
Overactive bladder
- A Randomised, Double-Blind, Placebo-Controlled, Multicenter Trial to Investigate the Preventive Effect of BIBR277 (Telmisartan (Micardis®, Gliosartan®, Kinzal®, Kinzalmono®, Predxal®, Pritor®, Samertan®, Telmisartan®
ClinicalTrials.gov Identifier: NCT00153088 - Completed
Diabetic Nephropathies
- A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine
ClinicalTrials.gov Identifier: NCT00000770 - Completed
HIV Infections
- A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past
ClinicalTrials.gov Identifier: NCT00002320 - Completed
HIV Infections
- Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection
ClinicalTrials.gov Identifier: NCT00013520 - Completed
HIV Infections
- A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination with Zidovudine in HIV-1 Infected Children
ClinicalTrials.gov Identifier: NCT00001066 - Completed
HIV Infections
- Double-Blind Comparison of the Efficacy of Continued Zidovudine versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment with Zidovudine
ClinicalTrials.gov Identifier: NCT00002035 - Completed
HIV Infections
- A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of P
ClinicalTrials.gov Identifier: NCT00002323 - Completed
HIV Infections
- A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
ClinicalTrials.gov Identifier: NCT00000712 - Completed
HIV Infections
- A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
ClinicalTrials.gov Identifier: NCT00000671 - Completed
HIV Infections
- A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002
ClinicalTrials.gov Identifier: NCT00000682 - Completed
HIV Infections
- The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine
ClinicalTrials.gov Identifier: NCT00002371 - Completed
HIV Infections
- Safety and Tolerance of Zidovudine with Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks
ClinicalTrials.gov Identifier: NCT00000670 - Completed
HIV Infections
- A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women
ClinicalTrials.gov Identifier: NCT00000897 - Completed
HIV Infections
- Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
ClinicalTrials.gov Identifier: NCT00086359 - Active, not recruiting
HIV Infections
- A Comparison of Zidovudine (AZT) Used Alone or in Combination with Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00001022 - Active, not recruiting
HIV Infections
- Four-Drug Combination Therapy with Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00006617 - Active, not recruiting
HIV Infections
- A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection
ClinicalTrials.gov Identifier: NCT00000652 - Active, not recruiting
HIV Infections
- A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
ClinicalTrials.gov Identifier: NCT00000751 - Active, not recruiting
HIV Infections; Pregnancy
- Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
ClinicalTrials.gov Identifier: NCT00004981 - Active, not recruiting
HIV Infections
- Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) with Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
ClinicalTrials.gov Identifier: NCT00011895 - Active, not recruiting
HIV Infections
- Safety of and Immune Response to Cyclosporine A in Combination with Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults with Acute HIV Infection
ClinicalTrials.gov Identifier: NCT00084149 - Active, not recruiting
HIV Infections
- Study of Anti-HIV Therapy Intensification
ClinicalTrials.gov Identifier: NCT00034086 - Active, not recruiting
HIV Infections
- A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women
ClinicalTrials.gov Identifier: NCT00000862 - Active, not recruiting
HIV Infections; Pregnancy
- A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants
ClinicalTrials.gov Identifier: NCT00000944 - Active, not recruiting
HIV Infections; Pregnancy
- A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given with Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
ClinicalTrials.gov Identifier: NCT00000887 - Active, not recruiting
HIV Infections; Pregnancy
- A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
ClinicalTrials.gov Identifier: NCT00000864 - Active, not recruiting
HIV Infections
- A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease
ClinicalTrials.gov Identifier: NCT00000662 - Active, not recruiting
HIV Infections
- Trial of UK-427,857 in Combination with Zidovudine/Lamivudine versus Efavirenz in Combination with Zidovudine/Lamivudine for the Treatment of HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00098293 - Active, not recruiting
HIV Infection
- Zidovudine and Lamivudine Given Once Versus Twice Daily
ClinicalTrials.gov Identifier: NCT00014014 - Active, not recruiting
HIV Infections
- An Open-Label Study of Nevirapine Plus Zidovudine (ZDV) and 3TC Treatment in Women Who Have Previously Received a Nevirapine Regimen for the Prevention of Mother to Child Transmission (pMTCT) of HIV-1.
ClinicalTrials.gov Identifier: NCT00144157 - Active, not recruiting
Acquired Immunodeficiency Syndrome
- Study of Zidovudine/Lamivudine and Nevirapine for Reduction of Mother-to-Child HIV Transmission During Breastfeeding
ClinicalTrials.gov Identifier: NCT00146380 - Recruiting
HIV Infections
- PI Vs. NNRTI Based Therapy for HIV Advanced Disease
ClinicalTrials.gov Identifier: NCT00162643 - Recruiting
Acquired Immunodeficiency Syndrome
- Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults and Adolescents in Senegal
ClinicalTrials.gov Identifier: NCT00100568 - Not yet recruiting
HIV Infections
- A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial Assessing the Rate of Decline of Lung Function with Tiotropium (Spiriva®) 18 Mcg Inhalation Capsule Once Daily in Patients with Chronic Obstructive Pulmonary Disaese (COPD).
ClinicalTrials.gov Identifier: NCT00144339 - Active, not recruiting
Pulmonary Disease, Chronic Obstructive
- Study of SU011248 in Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00254540 - Active, not recruiting
Renal Cell Carcinoma
- A Phase 3, Randomized, Open-Label, Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00262522 - Active, not recruiting
HIV Infection
- Capsule Endoscopy in Obscure GI Bleeding
ClinicalTrials.gov Identifier: NCT00203619 - Active, not recruiting
Obscure Gastrointestinal Bleeding
- A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.
ClinicalTrials.gov Identifier: NCT00551772 - Active, not recruiting
Alzheimer Disease
- Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule
ClinicalTrials.gov Identifier: NCT00579410 - Active, not recruiting
Esophagitis; Inflammation; Gastritis; Abdominal Pain; Heartburn
- (Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC
ClinicalTrials.gov Identifier: NCT00000679 - Completed
HIV Infections
- Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen
ClinicalTrials.gov Identifier: NCT00000903 - Completed
HIV Infections
- Antiviral Activity of and Resistance to Lamivudine in Combination with Zidovudine, Stavudine, or Didanosine
ClinicalTrials.gov Identifier: NCT00000838 - Completed
HIV Infections
- The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-dideoxyinosine or 2',3'-dideoxycytidine in Patients with Human Immunodeficiency Virus Disease
ClinicalTrials.gov Identifier: NCT00002001 - Completed
HIV Infections
- Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
ClinicalTrials.gov Identifier: NCT00017719 - Completed
HIV Infections; Pregnancy
- Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
ClinicalTrials.gov Identifier: NCT00000657 - Completed
AIDS Dementia Complex; HIV Infections
- A Comparison of BMS-232632 with Efavirenz, Each in Combination with Zidovudine-Lamivudine
ClinicalTrials.gov Identifier: NCT00013897 - Completed
HIV Infections
- Comparison of ddI Versus Zidovudine in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00000979 - Completed
HIV Infections
- Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC
ClinicalTrials.gov Identifier: NCT00001040 - Completed
HIV Infections
- A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00002307 - Completed
HIV Infections
- Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.
ClinicalTrials.gov Identifier: NCT00000678 - Completed
HIV Infections
- A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
ClinicalTrials.gov Identifier: NCT00000720 - Completed
HIV Infections
- A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination with Zidovudine (ZDV) versus ZDV alone in HIV-1 Infected Individuals with CD4 Counts of 200-500mm3
ClinicalTrials.gov Identifier: NCT00002124 - Completed
HIV Infections
- Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China
ClinicalTrials.gov Identifier: NCT00100594 - Completed
HIV Infections
- The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients with No Symptoms of Infection
ClinicalTrials.gov Identifier: NCT00002179 - Completed
HIV Infections
- The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00001075 - Completed
HIV Infections
- The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More than 12 Weeks
ClinicalTrials.gov Identifier: NCT00001063 - Completed
HIV Infections
- The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.
ClinicalTrials.gov Identifier: NCT00000629 - Completed
HIV Infections
- The Effects of Zidovudine on the Blood of HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00000965 - Completed
HIV Infections
- Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected with HIV
ClinicalTrials.gov Identifier: NCT00001119 - Completed
HIV Infections
- Evaluation of Patients Who Have Not Had Success with Zidovudine
ClinicalTrials.gov Identifier: NCT00001025 - Completed
HIV Infections
- Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.
ClinicalTrials.gov Identifier: NCT00000818 - Completed
HIV Infections
- Evaluation of the Interaction Between Acetaminophen and Zidovudine
ClinicalTrials.gov Identifier: NCT00000731 - Completed
HIV Infections
- Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and Zidovudine
ClinicalTrials.gov Identifier: NCT00000734 - Completed
HIV Infections
- Evaluation of the Interaction Between Low Dose Sulfamethoxazole-Trimethoprim and Zidovudine
ClinicalTrials.gov Identifier: NCT00000732 - Completed
HIV Infections
- Fortovase (Saquinavir) Given with Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
ClinicalTrials.gov Identifier: NCT00000920 - Completed
HIV Infections; Pregnancy
- Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC
ClinicalTrials.gov Identifier: NCT00000711 - Completed
HIV Infections; Cytopenias
- Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination with Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3
ClinicalTrials.gov Identifier: NCT00001993 - Completed
HIV Infections
- Lopinavir/Ritonavir in Combination with Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects
ClinicalTrials.gov Identifier: NCT00043953 - Completed
HIV Infections
- Methadone Effects on Zidovudine (ZDV, AZT) Disposition
ClinicalTrials.gov Identifier: NCT00000800 - Completed
HIV Infections
- A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
ClinicalTrials.gov Identifier: NCT00000823 - Completed
HIV Infections
- A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 mg q 8 h Versus 1,200 mg q 12 h in Combination with Zidovudine and 3TC
ClinicalTrials.gov Identifier: NCT00002208 - Completed
HIV Infections
- An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection
ClinicalTrials.gov Identifier: NCT00000647 - Completed
HIV Infections
- An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts
ClinicalTrials.gov Identifier: NCT00000709 - Completed
AIDS Dementia Complex; HIV Infections
- An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or
ClinicalTrials.gov Identifier: NCT00002255 - Completed
HIV Infections
- Open-Label Program of Dideoxycytidine ( ddC ) to be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease
ClinicalTrials.gov Identifier: NCT00002081 - Completed
HIV Infections
- An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients with HIV Infection (CD4+ Cell Count < 400/mm3)
ClinicalTrials.gov Identifier: NCT00000649 - Completed
HIV Infections
- A Pharmacokinetic Study of L-697,661 Alone and in Combination with Zidovudine
ClinicalTrials.gov Identifier: NCT00000628 - Completed
HIV Infections
- The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient
ClinicalTrials.gov Identifier: NCT00000661 - Completed
HIV Infections
- A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)
ClinicalTrials.gov Identifier: NCT00000742 - Completed
HIV Infections
- A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine
ClinicalTrials.gov Identifier: NCT00002096 - Completed
Cytomegalovirus Infections; HIV Infections
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
ClinicalTrials.gov Identifier: NCT00000976 - Completed
HIV Infections
- A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)
ClinicalTrials.gov Identifier: NCT00002014 - Completed
HIV Infections
- Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients with Persistent Generalized Lymphadenopathy
ClinicalTrials.gov Identifier: NCT00000728 - Completed
HIV Infections
- A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease
ClinicalTrials.gov Identifier: NCT00000696 - Completed
HIV Infections
- A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease
ClinicalTrials.gov Identifier: NCT00000656 - Completed
HIV Infections
- A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy
ClinicalTrials.gov Identifier: NCT00000803 - Completed
HIV Infections
- A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV
ClinicalTrials.gov Identifier: NCT00000791 - Completed
HIV Infections
- A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients
ClinicalTrials.gov Identifier: NCT00002190 - Completed
HIV Infections
- Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00000687 - Completed
Sarcoma, Kaposi; HIV Infections
- A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease
ClinicalTrials.gov Identifier: NCT00002110 - Completed
HIV Infections
- A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
ClinicalTrials.gov Identifier: NCT00000750 - Completed
HIV Infections
- A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection
ClinicalTrials.gov Identifier: NCT00002270 - Completed
HIV Infections; Leukoencephalopathy, Progressive Multifocal
- A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases
ClinicalTrials.gov Identifier: NCT00002044 - Completed
AIDS Dementia Complex; Neuromuscular Diseases; HIV Infections
- Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One treatment arm receives placebo)
ClinicalTrials.gov Identifier: NCT00000765 - Completed
HIV Infections
- Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care
ClinicalTrials.gov Identifier: NCT00028327 - Completed
HIV Infections
